Bayamban, Drixine Grace .
HRN: 11-72-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/11/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/11/2025
04/12/2025
IVT
500 Mg
X 3 Doses
Thickly MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes